Schober, Rafaëla
Brandus, Bianca
Laeremans, Thessa
Iserentant, Gilles
Rolin, Camille
Dessilly, Géraldine
Zimmer, Jacques
Moutschen, Michel
Aerts, Joeri L.
Dervillez, Xavier
Seguin-Devaux, Carole http://orcid.org/0000-0003-0636-5222
Funding for this research was provided by:
Fonds National de la Recherche Luxembourg (PRIDE/11012546/Next Immune-DTU, PRIDE17/11823097/MICROH-DTU)
Ministère de l'Enseignement Supérieur et de la Recherche (LIH GBB 98000005)
Article History
Received: 10 August 2023
Accepted: 27 October 2023
First Online: 7 November 2023
Declarations
:
: Blood samples of HIV-1 infected individuals were collected at the Centre Hospitalier de Luxembourg. The study was approved by the National Ethics Committee of Luxembourg (CNER; Ethical approval n° 201105/07). Cord blood was provided by the Cord Blood Bank Central Hospital University (Liège, Belgium) and was collected after obtaining written informed consent. The protocol (reference 1513) was accepted by the Ethics Committee of the University Hospital of Liège (reference B70720072580). Each participant signed an informed consent in accordance with national guidelines and the Declaration of Helsinki.
: A patent application has been filed for NaMiX (LIH-023-PCT WO202381120) by the inventors (R.S., B.B., J.Z., X.D., C.S.D.). The authors have declared that no other conflict of interest exists.